SCHEMBL25538200

SCHEMBL25538200

CC1(C)c2cc(-c3ccc(-c4cc(-c5ccccc5-c5ccccc5)nc(-c5ccc(-c6ccccc6)cc5)n4)c4ccccc34)ccc2-c2cc3ccccc3cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
PDK2 Q15119 4/20 0.35
RARB P10826 1/20 0.34
RARG P13631 1/20 0.34
RXRA P19793 1/20 0.34
NTSR1 P30989 1/20 0.34
ACACA Q13085 1/20 0.34
LMNA P02545 3/20 0.33
MAOB P27338 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
MAOA P21397 1/20 0.33
PTGS2 P35354 1/20 0.32
POLB P06746 1/20 0.32
ENPP3 O14638 1/20 0.32
ENPP1 P22413 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25536324 1.00 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25536313 0.99 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25537724 0.98 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25537354 0.98 PDK2 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25538326 0.95 RARB (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25536872 0.95 RARB (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25536350 0.94 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25536348 0.94 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25536866 0.94 RARB (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25536347 0.94 CYP1A1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MEN1 267/4885KMT2A 1094/4885MAPT 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.